DANBURY, Conn.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today announced that its commercial manufacturing facility, custom-built for the production of its proprietary insulin therapy, has been awarded two Facility of the Year 2010 category awards for process innovation and equipment innovation.
